Clinical Trial

Use of a New Method for the Microbiological Diagnosis of Severe Corneal Infection

Study acronym: ABCORFILM
Recruiting
View on ClinicalTrials.gov →
Summary
Microbial keratitis is a severe and often blindness-inducing pathology which represents today the first reason for long-term hospitalization (more than 5 days) in ophthalmology. Its diagnosis is clinical and leads to an immediate hospitalization in the presence of serious criteria (Mackie classification). The entire process of microbiological diagnosis requires several days before etiological confirmation and therefore delays the initiation of targeted therapy. Recently, new PCR systems allowing the detection of 18 to 27 pathogens in 75 minutes have been developed. Their use could thus be transposed to ophthalmology by adapting the microbiological diagnostic technique to samples currently taken by swabbing the cornea. The investigators will compare their diagnosis performance versus conventional methods on patients who suffered for a microbial keratitis with severity criteria.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-05-25; most recent amendment 2024-09-06.
Status change: Not Yet Recruiting → Recruiting 2024-01-18
Trial Details
NCT Number NCT05888987
Lead Sponsor CHU de Reims
Conditions Infectious Keratitis, Microbial Keratitis, Corneal Infection
Enrollment 46 participants
Start Date 2023-07-07
Primary Completion 2027-01-07 (estimated)
Study Completion 2027-08-07 (estimated)
Updated on ClinicalTrials.gov 2024-09-19